PT
Menu
Search
Sections
Home
News
Analysis
Features
Comment
Projects
Data Insights
Sectors
Clinical Trials
Drug Manufacturers
Therapy Area
Cardiovascular
Central Nervous System
Immunology
Infectious Disease
Oncology
Respiratory
Themes
Artificial Intelligence
Corporate Governance
Cloud
Cybersecurity
Environmental Sustainability
Internet of Things
Robotics
Social Responsibility
Covid-19
Insights
Deals
Jobs
Filings
Patents
Social Media
Companies
Company A-Z
Company Categories
Products & Services
Company Releases
White Papers
Videos
Buyer's Guides
Partner Content
Pricing and Market Access
Events
Reports
Premium Insights
Excellence Awards
Magazine
Newsletters
GlobalData
About us
Advertise With Us
Contact Us
Our Marketing Solutions
GlobalData Reports
Visit GlobalData
From Our Partners
Transforming MedTech and Pharma using Software as a Medical Device (SaMD)
Accelerating Biopharmaceutical Innovation
Precision medicine and digital health innovation for disease diagnosis, care and treatment
Enabling process intensification in biopharma manufacturing
Specialty drug launch strategy and operations
The next chapter of clinical trial services
Future Pharma Services
Putting quality first in the pharma supply chain
Enabling better biopharmaceutical manufacturing
Pharmaceutical Grade Silicone Manufacturer
Maximising molecule potential
News
Analysis
Sections
Features
Comment
Projects
Data Insights
Latest
Results from Rybrevant trial solidify Janssen’s foothold in EGFR-mutated NSCLC
Bristol Myers Squibb’s Reblozyl reinforces market share in first-line MDS Space
Do diet drugs pull their weight?
Sectors
Sections
Clinical Trials
Drug Manufacturers
Therapy Area
Latest
Results from Rybrevant trial solidify Janssen’s foothold in EGFR-mutated NSCLC
Bristol Myers Squibb’s Reblozyl reinforces market share in first-line MDS Space
FDA to start review of subcutaneous Entyvio for Crohn’s disease
Themes
Sections
Artificial Intelligence
Cloud
Corporate Governance
Cybersecurity
Environmental Sustainability
Internet of Things
Robotics
Social Responsibility
Covid-19
Latest
Signal: Roche to refile subcutaneous Tecentriq with FDA after UK approval
Menarini signs agreement for Astellas’s rheumatoid arthritis therapy
FDA approves Pfizer-BioNTech’s Omicron XBB.1.5-adapted Covid-19 vaccine
Insights
Sections
Deals
Jobs
Filings
Patents
Social Media
Latest
Signal: Roche to refile subcutaneous Tecentriq with FDA after UK approval
Signal: Kroger to pay up to $1.4bn to settle opioid crisis lawsuits
Signal: Pharma giant Novartis to spin-off generics brand
Companies
Sections
Company A-Z
Company Categories
Products & Services
Company Releases
White Papers
Videos
Buyer's Guides
Partner Content
Latest
Why prefilled vial capacity is key to a competitive edge in pharmaceuticals manufacturing
Launching pharmaceuticals in the Nordics: Opportunities and challenges
Sustainability in the pharma industry: The way forward
Events
Reports
Premium Insights
Newsletters
PT
All articles by Denis Ilinov
Denis Ilinov
Jobs Data
US pharma industry IT recruitment activity rises 0.9% in January 2022
Jobs Data
UK pharma industry IT recruitment activity drops 7.6% in January 2022
Jobs Data
Australia’s pharma industry IT recruitment activity rises 10.6% in January 2022
Jobs Data
Asia-Pacific’s pharma industry IT hiring activity drops 5.1% in January 2022
View more
Most Popular
Acesion wins €45m in Series B funding to develop atrial fibrillation therapy
Coherus Biosciences gets hit with CRL for pegfilgrastim biosimilar injectable
Sandoz scores European approval for Tysabri biosimilar
